Security of Pharmaceuticals - Comparing US and EU Standards – Free Download - METTLER TOLEDO
White Paper

Security of Pharmaceuticals - Comparing US and EU Standards – Free Download

White Paper

Understanding the main provisions of legal frameworks for pharmaceutical manufactures

Security of Pharmaceuticals - Comparing US and EU Standards
Security of Pharmaceuticals - Comparing US and EU Standards

The EU's counterfeit protection directive 2011/62 / EU Falsified Medicine Directive (FMD), and the Drug Supply Chain Security Act (DSCSA) have been introduced to ensure greater patient protection. They set the stage for greater pharmaceutical security.

This white paper describes the legal frameworks adopted by the European Union and the United States and the resulting requirements for pharmaceutical companies. It provides practical tips on best practice for coding, production processes, packaging design and data infrastructure.

In addition, the white paper compares the similarities and differences between the FMD and the DSCSA in the following areas:

  • Tamper protection
  • Supply chain documentation
  • Three-pronged security design
  • Data matrix codes, product identifiers & SNI
  • Protection against counterfeiting
  • Management of serialization data
  • Aggregation

Download this informative white paper to learn more

Both the FMD as well the DSCSA require inspection systems with the ability to print serialized 2D codes to verify them and which can handle communication with a centralized database/ERP system. Manufacturers who make their production lines fit both the requirements of US serialization from 27 November 2017 as well as the EU's FMD requirements from 9 February 2019 will be in a position to comply with the pending 2023 DSCSA specifications.

Europe and the United States are considered the world leaders in the safest pharmaceutical markets for patients. However: With 840 million inhabitants, and two-thirds of global pharmaceutical sales, the US and Europe are also a lucrative target for drug crime. New sales channels such as the internet make it increasingly easier for pharmaceutical counterfeiters to market counterfeits directly or to infiltrate the supply chain. These new legal frameworks have been introduced to combat this global threat.

Related White Papers

Understanding Regulations in Medical Device Labeling
This white paper looks at the aggregation process which defines the track and trace data relationship between the parent and child.
Food Safety Standards and Legislation White Paper
This white paper looks at the Communicating Reliable Information and Standards for Agriculture and Logistics (CRISTAL); a communications framework for...
Tamper-Evident Pharmaceutical Packaging
This white paper explains the implications of the EU directive 2011/62/EU and EN 16679 and how this will affect pharmaceutical packaging. It specifica...
Serialization - Are You Ready?
The global threat of counterfeit medicines is growing. Quickly learn how to reliably track and trace medicinal products by integrating serialization s...